Michael Kelso

Principal Scientist at Race Oncology

Professor Michael Kelso is an internationally experienced researcher, with more than 25 years of R&D experience across a wide range of areas in medicinal chemistry, including oncology, antimicrobial drug development and drug formulation.

Prior to joining Race Oncology, he was a Professor of Medicinal Chemistry at the University of Wollongong and earlier in his career a NH&MRC CJ Martin Postdoctoral Research Fellow at the Department of Chemistry, The Scripps Research Institute, CA, USA.

Prof Kelso has published 69 scientific research papers and 7 patents and has attracted 18 grants from the National Health and Medical Research Council (NH&MRC), Australian Research Council (ARC), and the US National Institutes of Health (NIH), as well as industry and charity foundations.

Prof Kelso holds a Bachelor of Medicinal Chemistry (First Class Honours) from the University of Wollongong and a PhD from University of Queensland. He is a member of the Royal Australian Chemical Institute and the American Chemical Society.

Location

Sydney, Australia

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Race Oncology

Race Oncology (ASX: RAC) is a precision oncology company with a Phase II/III cancer drug called Bisantrene.


Industries

Headquarters

Sydney, Australia

Employees

1-10

Links